IASLC Newsletter - August 2018

In the last 20 years, the decision-making process of the entire thoracic oncology community has been influenced by several windstorms that profoundly modified our diagnostic and therapeutic strategies.

IASLC Newsletter - July 2018

Our annual meeting, the IASLC 19th World Conference on Lung Cancer (WCLC 2018), is quickly approaching

IASLC Newsletter - June 2018

Newer treatment options, biomarker-based patient segmentation and the availability of biomarker-based treatment approaches have added to treatment complexity over the years.

IASLC Newsletter - May 2018

With this corner, I would like to draw your attention to our new strategic plan.

IASLC Newsletter - April 2018

In my first president’s corner in November 2017, I discussed the IASLC's strategic plan, an initiative that will precisely define the organization's objectives and the time frame that will be necessary in order to achieve them.

IASLC Newsletter - March 2018

Immunotherapy has recently emerged as a new treatment modality in lung cancer, and reactivating immune responses that are silenced by immune checkpoints is an idea that has recently gained a lot of interest.